Articles in Scholarly Journals [Incomplete List]

1. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men
   Cancer, vol. 109, no. 6, pp. 1192–1202, 2007
2. Education predicts quality of life among men with prostate cancer cared for in the department of Veterans affairs
   Cancer, vol. 109, no. 9, pp. 1769–1776, 2007
3. The basic biochemistry and molecular events of hormone therapy
   Current Urology Reports, vol. 8, no. 3, pp. 224–232, 2007
4. Editorial Comment on: Marked Gene Transcript Level Alterations Occur Early during Radical Prostatectomy
   European Urology, 2007
5. Role of Post-Chemotherapy Surgery in Germ Cell Tumors
   Urologic Clinics of North America, vol. 34, no. 2, pp. 199–217, 2007
6. Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer
   Cancer Research, vol. 67, no. 10, pp. 5033–5041, 2007
7. Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
   Journal of Clinical Oncology, vol. 25, no. 15, pp. 2035–2041, 2007
8. Persistent Intraprostatic Androgen Concentrations after Medical Castration in Healthy Men
   Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 10, pp. 3850–3856, 2006
9. Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis
   Journal of Clinical Oncology, vol. 24, no. 23, pp. 3763–3770, 2006
10. Microarray Analysis and Tumor Classification
    New England Journal of Medicine, vol. 355, no. 9, pp. 960–960, 2006
11. A molecular correlate to the Gleason grading system for prostate adenocarcinoma
    Proceedings of the National Academy of Sciences, vol. 103, no. 29, pp. 10991–10996, 2006
12. Effect of medical castration on CD4+CD25+ T cells, CD8+ T cell IFN-  expression, and NK cells: a physiological role for testosterone and/or its metabolites
    AJP: Endocrinology and Metabolism, vol. 290, no. 5, pp. E856–E863, 2006
13. Incidence of testicular germ cell cancers in U.S. children: SEER program experience 1973 to 2000
    Urology, vol. 68, no. 2, pp. 402–405, 2006
14. Incidence of primary urethral carcinoma in the United States
    Urology, vol. 68, no. 6, pp. 1164–1168, 2006
15. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder
    Cancer, vol. 107, no. 4, pp. 721–728, 2006
16. Intermittent Androgen Deprivation: Clinical Experience and Practical Applications
    Urologic Clinics of North America, vol. 33, no. 2, pp. 167–179, 2006
17. Polymorphisms in the glutathione S-transferaseM1,T1, andP1 genes and prostate cancer prognosis
    The Prostate, vol. 66, no. 14, pp. 1535–1541, 2006
18. Statins and the Risk of Cancer
    JAMA: The Journal of the American Medical Association, vol. 295, no. 23, pp. 2721–2721, 2006
19. Rectal fistulas after prostate brachytherapy
    International Journal of Radiation Oncology*Biology*Physics, vol. 63, no. 1, pp. 150–154, 2005
20. Editorial comment
    Urologic Oncology: Seminars and Original Investigations, vol. 23, no. 6, pp. 439–440, 2005
21. PROSTATE CANCER IN MEN USING TESTOSTERONE SUPPLEMENTATION
    Journal of Urology, The, vol. 174, no. 2, pp. 534–538, 2005
22. Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer
    International Journal of Urology, vol. 12, no. 11, pp. 1012–1013, 2005
23. Prognostic Value of Combined "Triple"-Reverse Transcription-PCR Analysis for Prostate-Specific Antigen, Human Kallikrein 2, and Prostate-Specific Membrane Antigen mRNA in Peripheral Blood and Lymph Nodes of Prostate Cancer Patients
    Clinical Cancer Research, vol. 10, no. 17, pp. 5808–5814, 2004
24. Does the Who and How of Surgery in Bladder Cancer Matter?
    Journal of Clinical Oncology, vol. 22, no. 14, pp. 2762–2764, 2004
25. Is prediagnosis PSA velocity predictive of the risk of death from prostate cancer following radical prostatectomy?
    Nature Clinical Practice Urology, vol. 1, no. 2, Article ID ncpuro0046, 1 pages, 2004
26. Value of Urethral Wash Cytology in the Retained Male Urethra After Radical Cystoprostatectomy
    The Journal of Urology, vol. 169, no. 3, pp. 961–963, 2003
27. Evidence That the Human Gene for Prostate Short-chain Dehydrogenase/Reductase (PSDR1) Encodes a Novel Retinal Reductase (RalR1)
    Journal of Biological Chemistry, vol. 277, no. 32, pp. 28909–28915, 2002
28. URODYNAMIC EVALUATION AND LONG-TERM RESULTS OF THE ORTHOTOPIC GASTRIC NEOBLADDER IN MEN
    The Journal of Urology, vol. 164, no. 2, pp. 356–359, 2000
29. ENDOSCOPIC TREATMENT OF BLADDER OUTLET OBSTRUCTION IN MEN AFTER PANCREAS TRANSPLANTATION
    The Journal of Urology, vol. 162, no. 2, pp. 335–338, 1999
30. Primary penile lymphoma: diagnostic difficulties and management options
    Urology, vol. 54, no. 2, p. 366, 1999
31. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
    The Prostate, vol. 39, no. 4, pp. 234–239, 1999
32. ENDOUROLOGICAL TREATMENT OF URETEROENTERIC STRICTURES: EFFICACY OF ACUCISE* ENDOURETEROTOMY
    The Journal of Urology, vol. 162, no. 3, pp. 696–698, 1999
33. Serum percent free prostate-specific antigen in metastatic prostate cancer
    Urology, vol. 52, no. 3, pp. 366–371, 1998
34. TRANSITION ZONE PROSTATE SPECIFIC ANTIGEN DENSITY: LACK OF USE IN PREDICTION OF PROSTATIC CARCINOMA
    The Journal of Urology, vol. 160, no. 1, pp. 77–82, 1998